vTv Therapeutics stockholders elect seven directors and approve 2024 Equity Incentive Plan

vTv Therapeutics Inc.

At the June 11, 2024 annual meeting, stockholders elected Srinivas Akkaraju, Raymond Cheong, Fahed Al Marzooqi, Richard Nelson, Anne Phillips, Paul Sekhri, and Daniel Spiegelman as directors.
Stockholders approved the 2024 Equity Incentive Plan with 1,814,842 votes for, 103,928 against, and 1,925 abstentions.
Ernst & Young LLP was ratified as independent auditor for fiscal 2024 with 2,106,193 votes for, 9,580 against, and 99,191 abstentions.
All director nominees received between 1,887,098 and 1,913,689 votes for, with 294,269 broker non-votes each.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.